Hims & Hers Health, Inc. (HIMS)
| Market Cap | 1.58B |
| Revenue (ttm) | 261.76M |
| Net Income (ttm) | -79.92M |
| Shares Out | 191.92M |
| EPS (ttm) | -0.49 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 3,773,873 |
| Open | 8.31 |
| Previous Close | 8.46 |
| Day's Range | 7.52 - 8.33 |
| 52-Week Range | 6.71 - 25.40 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Est. Earnings Date | Nov 11, 2021 |
About HIMS
Hims & Hers Health, Inc. operates a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals. The company offers a range of health and wellness products and services available for purchase on its websites directly by customers. It provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, as well as cosmetics and supplement products, primarily focusing on wellness, sexual health, skincare, and hair care. The company's cu...
Financial Performance
In 2020, HIMS's revenue was $148.76 million, an increase of 80.18% compared to the previous year's $82.56 million. Losses were -$18.11 million, -74.86% less than in 2019.
Financial StatementsNews
This Under-the-Radar Healthcare Stock Might Be on Sale for the Last Time
Investors are skeptical of Hims & Hers, pushing the stock back toward 52-week lows during September's sell-off. But are they right?
Vitamin Shoppe To Offer Haircare Products From Hims & Hers
Hims & Hers Health Inc (NYSE: HIMS) has partnered with The Vitamin Shoppe , a subsidiary of Franchise Group Inc (NASDAQ: FRG), to make its products available on the latter's platform. The financial term...
Hims & Hers Partners with The Vitamin Shoppe To Expand Availability Of Personal Care Offerings To Over 280 Stores and...
SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Inc. announced that their haircare products are now available both online and in-store at over 280 locations of The Vitamin Shoppe.
Hims & Hers Expands Customizable, Compounded Skincare Offerings With Hims Overnight Anti-Aging Duo, Hers Clear Skin S...
SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers, a multi-specialty telehealth platform, recently launched Hims Overnight Anti-Aging Duo and a customized Hers Clear Skin System.
Hims & Hers Launches Supplement Powder To Support Urinary Tract Health
Hims & Hers Health Inc (NYSE: HIMS) has expanded its women's health offerings by launching a D-Mannose dietary supplement powder to support urinary tract health on ForHers.com. The supplement powder com...
Hims & Hers Expands Women's Health Offerings With Support For Urinary Tract Health
SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers recently expanded its women's health offerings with the launch of a D-Mannose dietary supplement powder to support urinary tract health.
3 Stocks You'll Be Glad You Bought at These Prices
New companies in U.S. healthcare are bringing innovative, positive solutions to consumers.
Revolve To Offer Hims & Hers Health Products
Telehealth platform Hims & Hers Health Inc (NYSE: HIMS) has announced a partnership with Revolve Group Inc (NYSE: RVLV). Revolve will add a range of health and wellness solutions from Hims & Hers to its...
Hims & Hers Health to Present at Upcoming Financial Conferences
SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (“Hims & Hers”, NYSE:HIMS), the multi-specialty telehealth platform focused on providing modern personalized health and wellness experiences to c...
3 High-Growth Healthcare Stocks to Buy in September
All three are rapidly expanding into their own corners of America's $4 trillion per year healthcare sector.
2 Top Growth Stocks That Beat Expectations and Raised Guidance
Both grew their sales by more than 50% in their most recent quarters.
Gronk Spike: Hims & Hers Signs Rob Gronkowski To Partnership
One of the most well-known NFL players is partnering with a health care company to bring awareness to men's health issues and treatment. What Happened: Tampa Bay Buccaneers tight end Rob Gronkowski has ...
Hims & Hers Health CFO To Step Down; Reaffirms Outlook
Hims & Hers Health Inc (NYSE: HIMS) has announced that Spencer Lee will step down as its Chief Financial Officer. Lee will lead a six-month transition plan and continue to support the company until a ne...
Hims & Hers Partners With Rob Gronkowski to Bring Awareness to Men's Health Issues and Treatment
SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers partners with Rob Gronkowski to bring awareness to men's health issues and treatment.
Spencer Lee to Step Down as Hims & Hers Health Chief Financial Officer
SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the multi-specialty telehealth platform that provides modern personalized health and wellness experiences to consume...
Following Strong Growth, Hims & Hers Appoints Chief Growth Officer
SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers has appointed Mike Chi as the company's first-ever Chief Growth Officer.
What the Market Is Missing About Hims & Hers Health
This stock's share price is not matching up with the company's underlying performance. Let's investigate.
Why Hims & Hers Health Fell by Nearly 11% Today
New week, new price target decrease from an analyst.
Hims & Hers CFO on telehealth: There's a ‘ton of demand' in the market
Spencer Lee, CFO of Hims & Hers, joins Yahoo Finance Live to discuss the company's strong second-quarter results and breakdown what the future of telehealth looks like post-COVID. Watch the 2021 Berkshi...
Why Hims & Hers Health Shares Are Trading Higher Today
Hims & Hers Health Inc (NYSE: HIMS) is trading higher Thursday after the company announced better-than-expected second-quarter financial results and issued guidance above estimates. Hims & Hers Health r...
Why Hims & Hers Health Stock Popped Today
Shares of the telehealth company rose on better-than-expected second-quarter results.
Is the Options Market Predicting a Spike in Hims & Hers (HIMS) Stock?
Investors need to pay close attention to Hims & Hers (HIMS) stock based on the movements in the options market lately.
Hims & Hers Stock Shoot Up - What You Need To Know
A multi-specialty telehealth platform provider, Hims & Hers Health Inc (NYSE: HIMS), reported Q2 sales increased 69% Y/Y to $60.7 million, beating the consensus of $56.49 million. "This was a quarter o...
What's Going On With Hims & Hers Health's Stock After Hours?
Hims & Hers Health Inc (NYSE: HIMS) shares are trading higher by 13.1% at $8.48 in Wednesday's after-hours session after the company reported better-than-expected second-quarter EPS and sales results an...
Hims & Hers Health, Inc. Reports Second Quarter 2021 Financial Results
SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. ("Hims & Hers", NYSE: HIMS), a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, today reported f...